期刊文献+

前哨淋巴结转移状况对非前哨淋巴结转移预测价值的探讨 被引量:10

Value of sentinel lymph node metastasis status in predicting the presence of residual disease in the non-sentinel lymph node of breast cancer patients
原文传递
导出
摘要 目的 探讨前哨淋巴结(SLN)转移状况对非前哨淋巴结(nSLN)转移的预测价值;同时分析SLN1/n转移患者避免腋窝淋巴结清除(ALND)或是缩小手术范围的可行性。方法回顾山东省肿瘤医院1998年11月至2011年12月自开展前哨淋巴结活检(SLNB)以来的2265例乳腺癌患者的临床病理资料,其中接受ALND的乳腺癌患者1228例,根据SLN转移状况分成SLN(-)、SLN(1/n)、SLN(1/1)、SLN(n/N)和SLN(n/n)(ni〉2、Nt〉3和N〉n)5组,比较分析各状态间nSLN转移的特点。结果SLN(-)组nSLN转移率为11.8%(73/618),SLN(1/n)组为25.2%(65/258),SLN(1/1)组为49.6%(67/135),SLN(n/N)组为48.4%(60/124),SLN(n/n)组为65.6%(61/93),各组间nSLN转移情况差异均有统计学意义(均P〈0.01);两两比较发现,SLN(-)组患者与SLN(1/n)、(1/1)、(n/N)、(n/n)组患者nSLN转移情况比较差异均有统计学意义(均P〈0.01);SLN1/n转移患者与SLN(1/1)、(n/N)、(n/n)组患者nSLN转移情况之间的比较差异均有统计学意义(均P〈0.01);而SLN(1/1)、(n/N)、(n/n)组之间差异并无统计学意义(P=0.842、0.017、0.042,)(X2分割)。SLN1/n转移的患者腋窝Ⅱ、Ⅲ水平淋巴结转移的情况与SLN无转移的患者差异无统计学意义(P=0.012、0.570,)(2分割)。结论SLN转移状况与nSLN转移有相关性;SLN1/n转移的患者nSLN转移概率低于SLN1/1、n/N、n/n转移的患者,对于SLN1/n转移的部分患者仅行低位腋淋巴结清除术可能是安全的,但是不能仅通过SLN1/n转移这一指标免行ALND,需要综合考虑其他临床病理学因素的影响。 Objective To explore the value of sentinel lymph nodes (SLN) metastasis status in predicting the presence of residual disease in non-sentinel lymph nodes (nSLN) and the feasibility of avoiding or reducing the scope of axillary lymph node dissection (ALND) for patients with single positive SLN. Methods A retrospective study was conducted for 2265 patients with invasive breast carcinomas undergoing sentinel lymph nodes biopsy (SLNB) at Shandong Cancer Hospital between November 1999 and December 2011. And 1228 patients with axillary dissection were screened and divided into 5 groups of (-), (l/n), (1/1), (n/N), (n/n) (n1〉2, Nt〉3, N 〉 n) according to the status of SLN metastasis. Results The nSLN metastasis rate of SLN( - ) , (I/n) , (1/1) , (n/N) and (n/n) groups was 11.8% ( 73/618 ), 25.2% ( 65/258 ), 49. 6% ( 67/135 ), 48.4% (60/124) and 65.6% ( 61/93 ) respectively. A comparison of SEN( - ), (l/n), (1/1), (n/N), and (n/n) groups of nSLN metastasis showed a significant difference (P = 0. 000). The differences of nSLN metastasis between SLN ( - ) and other groups ( including I/n, 1/1, n/N, n/n group) were significant (P = 0. 000). This difference was also significant between SLN (l/n) and other positive groups (include 1/1, n/N, n/n group) (P = 0. 000),but not significant between SLN( 1/1 ), (n/N) and (n/n) groups (P = 0. 842, 0. 017, 0. 042 respectively, Chi-square segmentation). No significant difference existed between axillary lymph node metastasis on Level U and m of SLN 1/n group and SLN( - ) group (P = 0. 012, 0. 570, X2 segmentation). Conclusions The status of SLN metastasis is one of influencing factors for the nSLN metastasis of patients with invasivc breast cancer. The possibility of non-sentinel lymph node involvement for patients with single SLN metastasis was smaller than that of other SLN-positive patients. It is safe for some SLN 1/n patients to undergo low lymph node dissection. But ALND is not avoided for patients with single positive SLN (SLN 1/n n t〉 2 ). Their clinicopathological variables should be also considered.
出处 《中华医学杂志》 CAS CSCD 北大核心 2013年第14期1072-1075,共4页 National Medical Journal of China
关键词 乳腺肿瘤 前哨淋巴结活组织检查 淋巴转移 Breast neoplasms Sentinel lymph node biopsy Lymphatic matastasis
  • 相关文献

参考文献18

  • 1Krag DN, Anderson SJ, Julian TB, et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph- node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase Ⅲ trial. Lancet, 2007,8 : 881-888.
  • 2Kim T, Giuliano AE, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a meta analysis. Cancer, 2006, 106:4-16.
  • 3Stitzenberg KB, Meyer AA, Stern SL, et al. Extracapsular extension of the sentinel lymph node metastasis : a predictor of non- sentinel node tumor burden. Ann Surg, 2003, 237:6074512.
  • 4Fougo JL, Afonso M, Senhoraes SF, et al. Predictive factors for non-sentinel lymph node involvement in breast cancer patients with a positive sentinel node: should we consider sentinel node-related factors?. Clin Transl Oncol, 2009,11 : 165-171.
  • 5Klar M, Jochmann A, Foeldi M, et al. The MSKCC nomogram for prediction the likelihood of non-sentinel node involvement in a German breast cancer population. Breast Cancer Res Treat, 2008, 112:523-531.
  • 6Mustac E, Matusan-Ilijask K, Marijic B, et al. Predicting the likelihood of additional nodal metastases in breast carcinoma patients with positive sentinel node biopsy. Int J Surg Pathol, 2009,18:36-41.
  • 7Giuliano AE, McCall L, Beitsch P, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg,2010,252:426-433.
  • 8Krag D, Weaver D, Ashikga T, et al. The sentinel node in breast Cancer--a muhieenter validation study. N Engl J Med, 1998, 339 : 941-946.
  • 9Andersson Y, de Boniface J, Jsnsson PE , et al. Axillary recurrence rate 5 years after negative sentinel node biopsy for breast cancer. Br J Surg, 2012,99:226-231.
  • 10郑刚,杨靖,左文述,于志勇,刘岩松,郑美珠,王圣芳.中国乳腺癌前哨淋巴结活检验证阶段研究结果的系统评价[J].中华医学杂志,2011,91(6):361-365. 被引量:36

二级参考文献75

  • 1徐晓明,赵祥生,周建农,唐金海,陈环球,张彤,周大庆,莫伏根,秦建伟,姜爱仁.前哨淋巴结检测在乳腺癌治疗中的意义[J].中华普通外科杂志,2004,19(8):494-495. 被引量:12
  • 2江泽飞,姚开泰,宋三泰.乳腺癌治疗的新循证医学证据和临床实践[J].中华医学杂志,2005,85(43):3025-3027. 被引量:29
  • 3Giuliano AE.Mapping a pathway for axillary staging:a personal perspective on the current status of sentinel lymph node dissection for breast cancer[J].Arch Surg,1999,134(2):195-199.
  • 4Choi SH,Barsky SH,Chang HR.Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer[J].Breast J,2003,9(3):153-162.
  • 5Kitai T,Inomoto L Miwa M,et al.Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer[J].Breast Cancer,2005,12(3):211-215.
  • 6Giuliano AE,Kirgan DM,Guenther JM,et al.Lymphatic mapping and sentinel lymphadenectomy for breast cancer[J].Ann Surg,1994,220(3):391-398.
  • 7Canavese G,Gipponi M,Catturich A,et al.Pattern of lymphatic drainage to the sentinel lymph node in breast cancer patients[J].J Surg Oncol,2000,74(1):69-74.
  • 8Goyal A,Newcombe RG,Mansel RE,et al.Sentinel lymph node biopsy in patients with multifocal breast cancer[J].Eur J Surg Oncol,2004,30(5):475-479.
  • 9Hill AD,Tran KN,Akhurst T,et al.Lessons learned from 500 cases of lymphatic mapping for breast cancer[J].Ann Surg,1999,229(4):528-535.
  • 10Schwartz GF,Tannebaum JE,Jernignn AM,et al.Axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for carcinoma of the breast[J].Cancer,2010,116(5):1243-1251.

共引文献79

同被引文献39

  • 1徐晓明,赵祥生,周建农,唐金海,陈环球,张彤,周大庆,莫伏根,秦建伟,姜爱仁.前哨淋巴结检测在乳腺癌治疗中的意义[J].中华普通外科杂志,2004,19(8):494-495. 被引量:12
  • 2王永胜,左文述,刘娟娟,于志勇,刘岩松,李永清,周正波,刘雁冰,李济宇,赵桐,陈鹏.乳腺癌前哨淋巴结活检替代腋窝清扫术前瞻性非随机对照临床研究[J].外科理论与实践,2006,11(2):104-107. 被引量:32
  • 3Humphrey KL,Saksena MA,Freer PE,et al. To do or not to do: axillary nodal evaluation after ACOSOG Z0011 Trial [J]. Radio- graphics,2014,34(7) : 1807-1816.
  • 4Galimberti V,Cole BF,Zutrida S,et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometas- tases (IBCSG 23-01 ):a phase 3 randomised controlled trial Lancet Oneol, 2013,14 (4) : 297-305.
  • 5Zapletal O,Coufal O,SelingerováI,et al.The number of removed axillary sentinel lymph nodes and its impact on the diagnostic accuracy of sentinel lymph node biopsy in breast cancer[J].Rozhl Chir,2013,92(1):21-26.
  • 6Chagpar AB,Scoggins CR,Martin RC 2nd,et al.Are 3 sentinel nodes sufficient?[J].Arch Surg,2007,142(5):456-459.
  • 7Zakaria S,Degnim AC,Kleer CG,et al.Sentinel lymph node biopsy for breast cancer:how many nodes are enough?[J].J Surg oncol,2007,96(7):554-559.
  • 8Giuliano AE,McC all L,Beitsch P,et al.Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases:the American College of Surgeons Oncology Group Z0011 rando-mized trial[J].Annal surg,2010,252(3):426-433.
  • 9Francissen CM,Dings PJ,van Dalen T,et al.Axillary recurrence after a tumor positive sentinel lymph node biopsy without axillary treatment:a review of the literature[J].Ann Surg Oncol,2012,19(13):4140-4149.
  • 10姜军.提高对乳腺癌前哨淋巴结活检意义的认识[J].中华肿瘤防治杂志,2008,15(10):721-724. 被引量:12

引证文献10

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部